Search Ontology:
ChEBI
AZD3965
- Term ID
- CHEBI:234329
- Synonyms
-
- 5-[(4S)-4-hydroxy-4-methyl-1,2-oxazolidine-2-carbonyl]-3-methyl-6-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}-1-(propan-2-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
- 5-{[(4S)-4-hydroxy-4-methyl-1,2-oxazolidin-2-yl]carbonyl}-3-methyl-6-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}-1-(propan-2-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
- AZD 3965
- AZD-3965
- Definition
- A thienopyrimidine that is thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione substituted by isopropyl, methyl, (4S)-4-hydroxy-4-methyl-1,2-oxazolidine-2-carbonyl, and [5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl groups at positions 1, 3, 5, and 6, respectively. It is an inhibitor of monocarboxylate transporter 1 (Ki = 1.6 nM), and was previously in phase I clinical trials for the treatment of lymphomas and solid tumours.
- References
-
- cas:1448671-31-5
- pubmed:24277449
- pubmed:25281618
- pubmed:28385782
- pubmed:28923861
- pubmed:29050199
- pubmed:29674138
- pubmed:30617815
- pubmed:31010842
- pubmed:31823112
- pubmed:31937921
- pubmed:32076124
- pubmed:32203218
- pubmed:32529599
- pubmed:32604836
- pubmed:32833237
- pubmed:33540599
- pubmed:33963018
- pubmed:35011413
- pubmed:35618788
- pubmed:36342616
- pubmed:36652553
- pubmed:36884092
- pubmed:38140029
- pubmed:39465441
- pubmed:39810069
- pubmed:39810250
- pubmed:40043615
- pubmed:40347782
- pubmed:40400476
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from AZD3965
Phenotype where environments contain AZD3965
Phenotype modified by environments containing AZD3965
Phenotype affecting AZD3965
Human Disease Model